Genemedi produces core diagnostic ingredients for test of Cancer (hepatocellular carcinoma) and related syndrome. GeneMedi offers paired diagnostics grade Protein induced by vitamin K absence-II (PIVKA-Ⅱ) antibodies (monoclonal antibody, mab) and antigens for Cancer (hepatocellular carcinoma) rapid test kit of Protein induced by vitamin K absence-II (PIVKA-Ⅱ) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cancer (hepatocellular carcinoma ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Protein induced by vitamin K absence-II (PIVKA-II) is a potential screening marker for hepatocellular carcinoma (HCC). Protein induced by vitamin K absence-II (PIVKA-II), also known as des-γ-carboxy-prothrombin, has been identified as a serum biomarker linked to HCC. It is an abnormal prothrombin molecule produced as a consequence of an acquired defect in the posttranslational carboxylation of the prothrombin precursor in malignant cells. A quite large body of evidence indicates that PIVKA-II levels in the blood are increased in patients with HCC and importantly, an increasing amount of data indicates that it is more sensitive than AFP for differentiating HCC at all stages from patients with cirrhosis or chronic hepatitis. In addition, several studies from Asian countries have shown that serum PIVKA-II levels correlate with the HCC stage, as well as with survival of HCC patients, and a combination of PIVKA-II and AFP is currently used in Japan for HCC diagnosis and surveillance in accordance with the recommendations of the Clinical Practice Guidelines for HCC of that country.